Re: you won’t see anyone buying this
in response to
by
posted on
Dec 12, 2023 08:57AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Hi Fuzzy
I will put my 2 cents in here, The Zenith shares (ZHCLF) that trade on the expert market that have the same Cusip # as the original spunout shares have to be 100% real as the shares I have recently purcahsed on the expert market are showing up in the same investment account combined with my original spun out shares I was given in 2013 . No way to distinguish which ones were purchased or received . I will also say the reason Zenith Capital corp say they don't recoqnize the expert market shares is they don't like seeing a listed Share selling for .11cents USd when they are doing private placements at .88cents CDN , hard to sell if questioned by the qualified investor. Which brings me to what those investor know that we don't to why they would recently put down $9 million dollars on the latest PP . The true Zenith market valuation will come when a large BP decideds what is worth in any deal they decide to do with Zenith.... IMO